Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[64Cu]FBP8 PET for Early Detection of Intracardiac Thrombus in Amyloid Cardiomyopathy
NCT07560306Phase 3Recruiting
- Sponsor
- Brigham and Women's Hospital
- Start
- Jul 2026
- Primary completion
- Mar 2027
- Modality
- Peptide-Drug Conjugates
- Countries
- 1
01
Overview
A Phase 3 trial of [64Cu]FBP8 in intracardiac thrombus, cardiac amyloidosis, sponsored by Brigham and Women's Hospital. Started Jul 2026; status: recruiting.
02
Drugs
[64Cu]FBP8
03
Conditions
intracardiac thrombuscardiac amyloidosis
Beyond the preview
Go deeper on NCT07560306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07560306.